The HME/DME sector is at a strategic inflection point. Historically viewed as a margin-constrained distribution business, it is being reshaped by demographic growth, rising chronic disease burden, evolving reimbursement, and connected device proliferation.
As care increasingly shifts into the home, HME/DME providers are uniquely positioned to evolve from equipment fulfillment to scalable, home-embedded clinical infrastructure. By integrating device data, structured clinical workflows, and documented patient engagement, leading platforms can improve chronic disease control, reduce avoidable utilization, and strengthen payer partnerships.
This perspective outlines the strategic and operational implications of that transition — and what it takes to move from transactional distribution to longitudinal clinical engagement in a home-centered care model.
Please complete the form to receive this white paper. Upon submission, the white paper will be sent to your inbox.
